SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-007731
Filing Date
2022-01-12
Accepted
2022-01-12 16:49:25
Documents
6
Effectiveness Date
2022-01-12

Document Format Files

Seq Description Document Type Size
1 S-8 d217509ds8.htm S-8 65011
2 EX-5.1 d217509dex51.htm EX-5.1 6193
3 EX-23.1 d217509dex231.htm EX-23.1 1308
4 EX-99.2 d217509dex992.htm EX-99.2 236530
5 EX-99.3 d217509dex993.htm EX-99.3 33305
6 GRAPHIC g217509g0112085122264.jpg GRAPHIC 2703
  Complete submission text file 0001193125-22-007731.txt   347203
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262125 | Film No.: 22527044
SIC: 2834 Pharmaceutical Preparations